Koon‐Hou Mak

Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

Deepak L. Bhatt, Marcus Flather, Werner Hacke et al. · Journal of the American College of Cardiology · 2007 · 804 citations

Medicine, Cardiology, Internal Medicine +16

Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Koon‐Hou Mak, David J. Moliterno, Christopher B. Granger et al. · Journal of the American College of Cardiology · 1997 · 429 citations

Medicine, Cardiology, Internal Medicine +12

Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial

Jacqueline Saw, Danielle M. Brennan, Steven R. Steinhubl et al. · Journal of the American College of Cardiology · 2007 · 169 citations

Medicine, Pharmacology, Pharmacotherapy +6

Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

Steven R. Steinhubl, Deepak L. Bhatt, Peter B. Berger et al. · The American Journal of Cardiology · 2009 · 124 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study

Koon‐Hou Mak, Deepak L. Bhatt, Mingyuan Shao et al. · American Heart Journal · 2008 · 118 citations

Medicine, Cardiology, Pharmacotherapy +17